Cancer Research
-
CAR-T Sales in 2023: Gilead’s Yescarta Led at $1.5 Billion as Kymriah Slipped
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Alberta Cancer Foundation Commits $35 Million to Cancer Clinical Trials
EDMONTON, July 7 — Wendy Beauchesne has spent the last six years at the helm of the Alberta Cancer Foundation, and on…
-
BEYOND-PSA Study Invites 10,000 London Men to Test New Prostate Blood Test
LONDON, July 7 — A charity dedicated to tackling the most common cancer in men is hoping a new fundraising drive will…
-
Campbell Roy to Walk 537 Miles Across Scotland for Prostate Cancer Research
LONDON, July 7 — When Sir Chris Hoy, a six-time Olympic gold medalist and 11-time world champion cyclist, retired from competitive cycling,…
-
Owerko Centre Among Sites Sharing Alberta Cancer Foundation’s $35M Trials Fund
CALGARY, July 7 — A major investment announced yesterday is set to transform how quickly families across Alberta, and potentially beyond, can…
-
Strand Life Sciences Wins Indian Patent for Blood-Based Early Cancer Detection Test
BANGALORE, July 7 — A new patented technology from Strand Life Sciences is changing how doctors look for cancer in its earliest,…
-
Emily Whitehead, First Child Given CAR T Therapy, Cancer-Free More Than Nine Years Later
PHILLIPSBURG, N.J., July 7 — In the long, often heartbreaking history of childhood cancer research, there are a handful of moments that…
-
Oncologist Explains Why More Indians in Their 30s Are Being Diagnosed With Cancer
NEW DELHI, July 5 — For decades, cancer carried an image of being an illness that arrived late in life. That image…
-
Melbourne Banker’s Faint Chest Ache Turned Out to Be a Rare, Aggressive Cancer
MELBOURNE, July 5 — A young finance professional who dismissed a strange chest ache as a training strain was later diagnosed with…
-
UK Phase 2 Trial Opens to Test CY-101 in Rare Adrenal Cancer
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
ETH Zurich Builds Light-Controlled Switch That Wakes Dormant Lung Cancer Cells in the Lab
One number sits at the center of this new cancer research: the glucocorticoid receptor. It is a single protein. It is the…
-
Tel Aviv researchers uncover cancer growth mechanism
TEL AVIV, July 4 — Researchers at Tel Aviv University have documented a mechanism by which cancerous tumors hijack a routine immune-system…
-
Tata Memorial Papaya Leaf Extract Trial Faces Journal Concern Over Platelet Results
MUMBAI, July 3 — A new Phase III randomised clinical trial from Tata Memorial Centre’s GI medical oncology department has validated the…
-
Global Cervical Cancer Treatment Market to Hit $14.43B by 2034
NEW YORK, July 3 — Behind every number in a market report is a person. A mother, a sister, a friend. That’s…
-
Modified Vitamin B12 Crosses Blood-Brain Barrier and Targets Glioblastoma in Animal Study
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
Researchers Use Vitamin B12 to Deliver Glioblastoma Drug Past Blood-Brain Barrier
History is littered with promising cancer treatments that worked beautifully in mice and then fell apart in people. That sobering fact hangs…
-
Fatty Liver Linked to More Aggressive Spread of Bowel Cancer to the Liver, Study Finds
LONDON, July 3 — A fatty liver may be more than a metabolic warning sign. New research published in the journal Nature…
-
Vitamin B12 compound shows promise against deadly brain cancer
BOSTON — A modified form of vitamin B12, designed to deliver nitric oxide directly to tumors, has shown promise in early animal…
-
Modified vitamin B12 compound reaches brain tumors in animal study and stays active
A modified vitamin B12 compound that sneaks past the brain’s defenses has cleared animal testing for glioblastoma. The next steps are concrete,…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
Father’s Hope Shattered as Rare Brain Cancer Returns
SOUTH SHIELDS, July 2 — A first-time father has been told he has up to 12 months to live after a routine…
-
High-Fat Diet Worsens Wasting Syndrome in Mice with Lkb1 Mutation
CHICAGO — The numbers tell a grim story. In mice with lung tumors carrying a specific genetic flaw, a high-fat diet did…
-
Florida A&M researchers test new drug class targeting previously untreatable pancreatic cancer
For decades, the KRAS gene was considered untouchable. A single mutation in this gene drives rapid cell division in pancreatic ductal adenocarcinoma,…
-
Muscle cells found to release anti-cancer signals, study reveals
SINGAPORE — A new study from Duke-NUS Medical School suggests that aging muscle does not simply lose strength — it may also…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
New Studies Show Immunotherapy Gaining Ground in Lung, Prostate and Childhood Cancers
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Why Broad RAS-Targeting Drugs Mark a Turning Point in Treating Pancreatic Cancer
-
How At-Home Igalmi Differs From Traditional Treatments for Schizophrenia and Bipolar Agitation
-
Boron Neutron Capture Therapy Faces US Coverage Hurdles Over Cost and Data Gaps
-
FDA Proposes Slashing Companion Diagnostic Fees From $636,732 to $28,653
-
Biocon’s Pebrilzo FDA Approval Cements Its Role in Affordable Cancer Care
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























